Trial results for a feasibility study investigating Body Reprogramming for Severe Asthma were posted on ClinicalTrials.gov on 2025-07-11, enrolling 28 participants.
Background
Severe asthma often presents with extra-pulmonary symptoms that are not directly related to the lungs, and these symptoms can significantly impact a patient's quality of life. Body reprogramming (BR) is a non-drug intervention initially developed for fibromyalgia patients, focusing on evidence-based lifestyle changes to improve health and wellbeing. Given the similarities in the frequency and severity of multiple symptoms between severe asthma and fibromyalgia, investigators explored BR as a potential non-drug intervention for severe asthma patients.
Trial design
This completed study, designated as Phase NA, enrolled 28 participants to investigate Severe Asthma. The trial explored Body Reprogramming (BR) as a non-drug intervention aimed at improving health and wellbeing in patients with severe asthma.
Key results
The trial reported several key measurements related to participant engagement and completion in the Body Reprogramming course:
- For the outcome "Number of Participants Taking Part Who Completed All 4 Weeks of the Course", 13 participants completed all 4 weeks.
- For the outcome "Number and Percentage of Participants Who Complete the Study Questionnaires", 16 participants completed the study questionnaires (a second entry for this outcome shows 8 participants).
- For the outcome "Number of Participants Who Attended Two or More Sessions and Were Invited to a Follow-up Interview", 19 participants attended two or more sessions.
- For the outcome "Of Those Invited, the Number Who Accepted an Invitation to Take Part in a Follow-up Interview", 12 participants accepted an invitation for a follow-up interview.
What this means
These results provide insights into the feasibility of implementing Body Reprogramming as a non-drug intervention for individuals with severe asthma. The reported numbers on course completion, questionnaire completion, and attendance at sessions suggest varying levels of participant engagement with the intervention and study procedures. This data can inform the design and execution of future, larger-scale studies to assess the efficacy of Body Reprogramming in managing severe asthma symptoms and improving quality of life.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04980755, titled "Adapting Body Reprogramming for Severe Asthma: a Feasibility Study", were posted on 2025-07-11 on clinicaltrials.gov.